Published by Department of Health(DOH) on Oct. 13, 2022.
Requested from DOH by R. Cuartero at 03:40 PM on
Oct. 13, 2022.
Purpose: Data Management
Date of Coverage: 03/21/2022 - 10/13/2022
Tracking no: #DOH-858987578051
R.CUARTERO
Oct. 13, 2022, 3:40 p.m.
Based on DOH, these are the FDA-approved vaccines in Philippines: Pfizer-BioNTech , Johnson and Johnson Janssen, Oxford-AstraZeneca , Bharat BioTech, CoronaVac (Sinovac) , Moderna, Gamaleya Sputnik V, Sinopharm
Having DOH promote all FDA-approved vaccines as "Safe and Effective", please give me all the extensive and comprehensive clinical trials and studies to prove they prevent 100 % transmission of Covid-19 virus.
F.RECEIVING OFFICER
Oct. 14, 2022, 8:37 a.m.
October 14, 2022
Dear Ryan,
Thank you for your request dated Oct 13, 2022 under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch, for Covid-19 vaccines prevent virus transmission.
We received your request on Oct 13, 2022 and will respond on or before Nov 03, 2022 03:40:23 PM, in accordance with the Executive Order's implementing rules and regulations.
Should you have any questions regarding your request, kindly contact me using the reply function on the eFOI portal at https://pcoomaster08222018120000-dot-efoi-ph.appspot.com/requests/aglzfmVmb2ktcGhyHQsSB0NvbnRlbnQiEERPSC04NTg5ODc1NzgwNTEM, for request with ticket number #DOH-858987578051.
Thank you.
Respectfully,
FOI Receiving Officer
FOI Officer
F.MAKER
Oct. 14, 2022, 2:55 p.m.
Dear Ryan Cuartero
Please be informed that we have endorsed your request to the FDA for action. Kindly await for their response, thank you
R.CUARTERO
Oct. 18, 2022, 11:22 p.m.
Covid-19 vaccines prevent virus transmission
Tracking no: #DOH-858987578051
Greetings. As mentioned:
1. My request is endorsed to FDA for action.
2. You also mentioned the response will only be until November 3, 2022.
Now, I have some concerns I need answers to be provided. Please be informed that DOH and the mainstream media have been declaring all FDA approved vaccines in Philippines to be safe and effective. Therefore:
1. Why my concern on all covid-19 vaccines studies and clinical trials on its effectiveness in prevention of Covid-19 endorsed to FDA? Does it mean DOH do not have readily available data regarding the latter?
2. You also mentioned the response will only be until November 3, 2022. Why it will take such long time? DOH has been declaring all FDA-approved vaccines to be safe and effective, therefore, data regarding their effectivity on Covid-19 prevention should have been ready before the roll-out of the vaccine, March 2021.
3. I need my request Tracking no: #DOH-783801436017 expedited, November 3, 2022 is unreasonable, please provide me sooner date for the response on this request.
4. Please don’t make me wait for long time and you will get back with response: “No Data available”, is not acceptable.
Thank you.
R.CUARTERO
Oct. 18, 2022, 11:34 p.m.
Covid-19 vaccines prevent virus transmission
Tracking no: #DOH-858987578051
Greetings. As mentioned:
1. My request is endorsed to FDA for action.
2. You also mentioned the response will only be until November 3, 2022.
Now, I have some concerns I need answers to be provided. Please be informed that DOH and the mainstream media have been declaring all FDA approved vaccines in Philippines to be safe and effective. Therefore:
1. Why my concern on all covid-19 vaccines studies and clinical trials on its effectiveness in prevention of Covid-19 endorsed to FDA? Does it mean DOH do not have readily available data regarding the latter?
2. You also mentioned the response will only be until November 3, 2022. Why it will take such long time? DOH has been declaring all FDA-approved vaccines to be safe and effective, therefore, data regarding their effectivity on Covid-19 prevention should have been ready before the roll-out of the vaccine, March 2021.
3. I need my request Tracking no: #DOH-858987578051 expedited, November 3, 2022 is unreasonable, please provide me sooner date for the response on this request.
4. Please don’t make me wait for long time and you will get back with response: “No Data available”, is not acceptable.
Thank you.
F.MAKER
Jan. 17, 2023, 3:14 p.m.
January 17, 2023
Dear Ryan Cuartero,
I refer to my letter of Oct 13, 2022 03:40:23 PM about your request under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch, for Covid-19 vaccines prevent virus transmission.
In order for us to work further on your request, we need more information from you regarding your query.
We apologize for the delay of response to this eFOI Request. May we know if you still need the information? Kindly email us at [email protected]
You may use the reply function on the eFOI portal at https://pcoomaster11222017130000-dot-efoi-ph.appspot.com/requests/aglzfmVmb2ktcGhyHQsSB0NvbnRlbnQiEERPSC04NTg5ODc1NzgwNTEM, for request with ticket number #DOH-858987578051, to respond.
During the period of us awaiting your reply, your request will be put on hold. If we do not receive a reply on or before Apr 11, 2023 07:13:44 AM, your request will be closed.
We hope to hear from you at the soonest possible time.
Thank you.
Respectfully,
FOI Decision Maker
FOI Officer
F.MAKER
Jan. 19, 2023, 8:57 a.m.
January 19, 2023
Dear Ryan Cuartero,
Greetings!
Thank you for your request dated Oct 13, 2022 03:40:23 PM under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch.
Your Request
You asked for Covid-19 vaccines prevent virus transmission.
Response to Request
Your FOI request is approved.
The COVID-19 vaccines issued with Emergency Use Authorization (EUA) have been evaluated and approved based on the following:
1. The totality of the current evidence available, including data from adequate and well- known controlled trials, supports that the drug or vaccine is effective to prevent, diagnose, or treat COVID-19;
2. The known and potential benefits of the drug or vaccine, when used to diagnose, prevent, treat COVID-19, outweigh the known and potential risks of the drug or vaccine, if any; and
3. There is no adequate, approved and available alternative to the product for diagnosing, preventing or treating COVID-19. This condition is deemed present when no registered drug or vaccine exists in the country for diagnosing, preventing or treating COVID-19.
Based on the clinical trial data submitted to the National Regulatory Authorities (NRAs) around the world, including the Philippine FDA, there are no COVID-19 vaccines that have 100% efficacy, and are without any adverse events after immunization.
Please refer to the full product information through this link: https://www.fda.gov.ph/list-offda-issued-emergency-use-authorization/
There is a DOH-FDA pharmacovigilance system, which is a shared commitment with all stakeholders utilizing the COVID-19 vaccines. The Philippine FDA publishes an overview of reports of suspected adverse reactions to COVID-19 vaccines that are currently in use in the vaccination program of the Philippines. The reports of suspected adverse drug reactions issued on a weekly basis have provided timely and relevant information to healthcare professionals and the public on the safety of COVID-19 vaccines used in the vaccination program of the government as implemented by the National COVID-19 Vaccination Operations Center. In line with the high vaccination coverage and operational strategy, updates will be on a monthly basis.
Monitoring the safety of COVID-19 vaccines shall remain on a regular interval. All suspected adverse reaction reports received by the Philippine FDA regarding COVID-19 vaccines are posted on the FDA website for healthcare professionals and consumer awareness.
Please refer to this link regarding reports on suspected adverse reactions to COVID-19 vaccines: https://www.fda.gov.ph/wp-content/uploads/2022/10/Reports-of-suspected-adversereaction-to-COVID-19-vaccines-as-of-30-September-2022.pdf
Please refer also to the following websites for further information: US FDA CDC (2020) web article entitled: Overview, History, and How the Safety Process Works (https://www.cdc.gov/vaccinesafety/ensuringsafety/history/index.html)
“Before vaccines are approved by the Food and Drug Administration (FDA), scientists test them extensively to ensure they are effective and safe. Vaccines are the best defense we have against infectious diseases, but no vaccine is actually 100% safe or effective for everyone because each person’s body reacts to vaccines differently.”
We hope that the provided information has addressed all your concerns regarding the safety and effectiveness of Philippine FDA-approved COVID-19 Vaccines under EUA.
Thank you
Your right to request a review
If you are unhappy with this response to your FOI request, you may ask us to carry out an internal review of the response by writing to DOH Central Appeals and Review Committee, at [email protected]. Your review request should explain why you are dissatisfied with this response, and should be made within 15 calendar days from the date when you received this letter. We will complete the review and tell you the result within 30 calendar days from the date when we receive your review request.
If you are not satisfied with the result of the review, you then have the right to appeal to the Office of the President under Administrative Order No. 22 (s. 2011).
Thank you.
Respectfully,
FOI Decision Maker
FOI Receiving Officer
Is this request offensive?
Requests for personal information and vexatious requests are not considered valid requests for Official Information.
If you believe this request is not suitable, you can report it for attention by the site administrators.